Benjamin Ellingson

BIOENGINEERING

Associate Professor, David Geffen School of Medicine

Websites

Dr. Ellingson is the Director of the UCLA Brain Tumor Imaging Laboratory (BTIL), Co-Director of the Center for Computer Vision and Imaging Biomarkers, and a member of the UCLA Brain Tumor Program. Dr. Ellingson's research involves the development, testing, and implementation of advanced MRI and PET imaging biomarkers for the characterization of brain tumor biology and response evaluation in clinical trials. Dr. Ellingson has been a co-author on more than 100 peer-reviewed original research articles relating to neuroimaging. Dr. Ellingson has extensive experience performing data management and imaging analysis in multicenter clinical trials in brain cancer and he currently serves as the Chair of the Neuro-Imaging Committee for the NIH-funded Adult rain Tumor Consortium (ABTC), Chair of the Imaging Committee for the en and Catherine Ivy Foundation Consortium for Early Phase Clinical Trials, Chair of the Imaging Committee for the new Glioblastoma Global Adaptive Trial, is a member of the ACRIN head/neck/neuro committee imaging committee, and is the co-chair the imaging committee for specific brain tumor trials run by the Alliance for Clinical Trials in Oncology.

RESEARCH AND INTERESTS

Development, testing, and implementation of advanced MR and PET imaging biomarkers for the characterization of brain tumor biology and response to novel therapies.

NOTABLE PUBLICATIONS

https://pubmed.ncbi.nlm.nih.gov/?term=Ellingson+B+not+Ellingson+BA&sort=date

EDUCATION

B.S. 2003 Biomedical Engineering, Milwaukee School of Engineering
M.S. 2005 Biomedical Engineering, Marquette University
Ph.D. 2008 Functional Imaging, Marquette University & Medical College of Wisconsin
Fellowship 2008-2010 Radiology, Medical College of Wisconsin

AWARDS AND RECOGNITION

• Graduated with High Honors, Milwaukee School of Engineering, 2003 • 2nd Place, MS Student Paper Competition, Rocky Mount. Bioeng. Symp. 2005 • 2nd Place, PhD Student Competition, Rocky Mount. Bioeng. Symp., 2006 • Chairman’s Award, Rocky Mountain Bioengineering Symposium, 2008 • 1st Place Poster, Cancer Imaging, Annual Conference for the Int. Soc. for Magn. Reson. in Med., 2009 • Best Professional Presentation, Rocky Mountain Bioengineering Symposium, 2009 • W.S. Moore Young Investigator Award in Clinical Research, Annual Conference for the International Society for Magnetic Resonance in Medicine (ISMRM), 2010 • Cover of Journal of Neuro-Oncology, Vol. 72, No. 3, 2010 • Cover of Journal of Neuro-Oncology, Vol. 102, No. 1, 2011. • Cover of Journal of Neuro-Oncology, Vol. 105, No. 1, 2011 • RSNA Certificate of Merit, Radiological Society of North America Annual Meeting, 2011 • ACRIN Young Investigator Initiative Award, 2012. • Interview with the European Association of Neuro-Oncology (EANO) regarding brain tumor imaging publications, February 13, 2012 • Interview with the Association des neuro-oncologues d’expression française (AnOceF), the Scientific Association of Neuro-Oncologists in France, February 16, 2012 • Interview with American Journal of Neuroradiology News Digest, November 2012. • Cover of CNS Oncology, Vol. 2, Issue 1, 2013 • AJNR Editor’s Choice Award, Probabilistic Radiographic Atlas of Glioblastoma Phenotypes, AJNR Am J Neuroradiol 2013 34:533-540. • Cover of Journal of Neuro-Oncology, Vol. 112, No. 2, 2013 • Art of the Brain / Johnny Mercer Foundation Brain Tumor Research Award, 2013 • Cover of Journal of Neuro-Oncology, Vol. 116, No. 2, 2014 • Cover of Neuro Oncology, Vol. 16, Suppl. 7, 2014 • Cover of Journal of Neuro-Oncology, Vol. 134, No. 1, 2017 • Cover of Journal of Pain, Vol. 19, No. 5, 2018 • Cover of Journal of Neuro-Oncology, Vol. 139. No. 3, 2018 • Magna Cum Laude Award, Annual Conference for the International Society for Magnetic Resonance in o Medicine (ISMRM), 2019 (Differentiation of IDH1 mutant and wild-type gliomas based on metabolic signatures obtained from pH- and oxygen-sensitive molecular MRI) • Summa Cum Laude Award, Annual Conference for the International Society for Magnetic Resonance in o Medicine (ISMRM), 2019 (Low extracellular acidification in 1p/19q co-deleted gliomas confirmed using pH-weighted amine CEST-EPI, T2 relaxometry, and amino acid PET) • Outstanding Basic Science Faculty Teaching Award 2018-2019, Dept. of Radiological Sciences, UCLA • Cover of Neuro Oncology, Vol. 21, Issue 9, September 2019 • Society for Neuro-Oncology Award for Excellence in Neuro-Imaging, November 23, 2019 • Society for Neuro-Oncology Top Poster Award, Validation of diffusion MRI as an imaging biomarker for bevacizumab therapy in recurrent glioblastoma in a randomized phase III trial of bevacizumab with or without VB-111 (GLOBE), November 17, 2020 • Cover of Journal of Neuro-Oncology, Vol. 159, Issue 3, September 2022. • Cover of Journal of Neuro-Oncology, Vol. 160, Issue 1, October 2022. • Cover of NMR in Biomedicine, Vol. 36, Issue 6, June 2023. • Cover of Neuro Oncology, Vol. 25, Issue 6, June 2023. • Cover of Journal of Neuro-Oncology, Vol. 163, Issue 2, June 2023.